Shionogi & Co Ltd SGIOY:Grey Market

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
11.70UNCH (UNCH)
52 week range
10.10 - 13.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.70
  • 52 Week High13.67
  • 52 Week High Date03/07/24
  • 52 Week Low10.10
  • 52 Week Low Date07/11/23

Key Stats

  • Market Cap13,225.23M
  • Shares Out287.33M
  • 10 Day Average Volume71,490.5
  • Dividend0.26
  • Dividend Yield2.21%
  • Beta-
  • YTD % Change-2.27

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.70
  • 52 Week High13.67
  • 52 Week High Date03/07/24
  • 52 Week Low10.10
  • 52 Week Low Date07/11/23
  • Market Cap13,225.23M
  • Shares Out287.33M
  • 10 Day Average Volume71,490.5
  • Dividend0.26
  • Dividend Yield2.21%
  • Beta-
  • YTD % Change-2.27

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Shionogi & Co Ltd

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of...
Isao Teshirogi
Chairman of the Board, President, Chief Executive Officer, Representative Director
Takuko Sawada
Vice Chairman of the Board
Address
3-1-8, Dosho-machi, Chuo-ku
Osaka-shi, OSK
541-0045
Japan